Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Where can you publish?
Find journals in COLORADO Profiles by department and year.

Contact Us
If you have any questions or feedback please contact us.

Robert J Valuck

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Administration
Phone303/724-2890

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Iosifescu DV, Neborsky RJ, Valuck RJ. The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy. Neuropsychiatr Dis Treat. 2016; 12:2131-42.
      View in: PubMed
    2. Padula WV, Gibbons RD, Pronovost PJ, Hedeker D, Mishra MK, Makic MB, Bridges JF, Wald HL, Valuck RJ, Ginensky AJ, Ursitti A, Venable LR, Epstein Z, Meltzer DO. Using clinical data to predict high-cost performance coding issues associated with pressure ulcers: a multilevel cohort model. J Am Med Inform Assoc. 2016 Aug 18.
      View in: PubMed
    3. Padula WV, Gibbons RD, Valuck RJ, Makic MB, Mishra MK, Pronovost PJ, Meltzer DO. Are Evidence-based Practices Associated With Effective Prevention of Hospital-acquired Pressure Ulcers in US Academic Medical Centers? Med Care. 2016 May; 54(5):512-8.
      View in: PubMed
    4. Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016 Mar 15; 86(11):1014-21.
      View in: PubMed
    5. Valuck RJ, Libby AM, Anderson HD, Allen RR, Strombom I, Marangell LB, Perahia D. Comparison of antidepressant classes and the risk and time course of suicide attempts in adults: propensity matched, retrospective cohort study. Br J Psychiatry. 2016 Mar; 208(3):271-9.
      View in: PubMed
    6. Padula WV, Mishra MK, Makic MB, Wald HL, Campbell JD, Nair KV, Valuck RJ. Increased Adoption of Quality Improvement Interventions to Implement Evidence-Based Practices for Pressure Ulcer Prevention in U.S. Academic Medical Centers. Worldviews Evid Based Nurs. 2015 Dec; 12(6):328-36.
      View in: PubMed
    7. Feinstein JA, Feudtner C, Valuck RJ, Kempe A. The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients. Pharmacoepidemiol Drug Saf. 2015 Oct; 24(10):1049-57.
      View in: PubMed
    8. Padula WV, Valuck RJ, Makic MB, Wald HL. Factors Influencing Adoption of Hospital-Acquired Pressure Ulcer Prevention Programs in US Academic Medical Centers. J Wound Ostomy Continence Nurs. 2015 Jul-Aug; 42(4):327-30.
      View in: PubMed
    9. Padula WV, Makic MB, Mishra MK, Campbell JD, Nair KV, Wald HL, Valuck RJ. Comparative effectiveness of quality improvement interventions for pressure ulcer prevention in academic medical centers in the United States. Jt Comm J Qual Patient Saf. 2015 Jun; 41(6):246-56.
      View in: PubMed
    10. Padula WV, Makic MB, Wald HL, Campbell JD, Nair KV, Mishra MK, Valuck RJ. Hospital-Acquired Pressure Ulcers at Academic Medical Centers in the United States, 2008-2012: Tracking Changes Since the CMS Nonpayment Policy. Jt Comm J Qual Patient Saf. 2015 Jun; 41(6):257-63.
      View in: PubMed
    11. Czaja AS, Reiter PD, Schultz ML, Valuck RJ. Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research. J Pediatr Pharmacol Ther. 2015 May-Jun; 20(3):186-96.
      View in: PubMed
    12. Anderson HD, Pace WD, Brandt E, Nielsen RD, Allen RR, Libby AM, West DR, Valuck RJ. Monitoring suicidal patients in primary care using electronic health records. J Am Board Fam Med. 2015 Jan-Feb; 28(1):65-71.
      View in: PubMed
    13. Gibbons RD, Coca Perraillon M, Hur K, Conti RM, Valuck RJ, Brent DA. Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiol Drug Saf. 2015 Feb; 24(2):208-14.
      View in: PubMed
    14. Padula WV, Mishra MK, Makic MB, Valuck RJ. A framework of quality improvement interventions to implement evidence-based practices for pressure ulcer prevention. Adv Skin Wound Care. 2014 Jun; 27(6):280-4; quiz 285-6.
      View in: PubMed
    15. Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014 May 01; 189(9):1052-64.
      View in: PubMed
    16. Cochran BN, Flentje A, Heck NC, Van Den Bos J, Perlman D, Torres J, Valuck R, Carter J. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014 May 01; 138:202-8.
      View in: PubMed
    17. Hammermeister K, Bronsert M, Henderson WG, Coombs L, Hosokawa P, Brandt E, Bryan C, Valuck R, West D, Liaw W, Ho M, Pace W. Risk-adjusted comparison of blood pressure and low-density lipoprotein (LDL) noncontrol in primary care offices. J Am Board Fam Med. 2013 Nov-Dec; 26(6):658-68.
      View in: PubMed
    18. Bronsert MR, Henderson WG, Valuck R, Hosokawa P, Hammermeister K. Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study. J Am Board Fam Med. 2013 Sep-Oct; 26(5):529-38.
      View in: PubMed
    19. Czaja AS, Valuck RJ, Anderson HD. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events. Pharmacoepidemiol Drug Saf. 2013 Jun; 22(6):607-14.
      View in: PubMed
    20. Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. J Rheumatol. 2013 Jun; 40(6):809-17.
      View in: PubMed
    21. Valuck RJ, Anderson HO, Libby AM, Brandt E, Bryan C, Allen RR, Staton EW, West DR, Pace WD. Enhancing electronic health record measurement of depression severity and suicide ideation: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study. J Am Board Fam Med. 2012 Sep-Oct; 25(5):582-93.
      View in: PubMed
    22. Czaja AS, Valuck R. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence. Pharmacoepidemiol Drug Saf. 2012 Sep; 21(9):997-1004.
      View in: PubMed
    23. Reiter PD, Wathen B, Valuck RJ, Dobyns EL. Thrombosis risk factor assessment and implications for prevention in critically ill children. Pediatr Crit Care Med. 2012 Jul; 13(4):381-6.
      View in: PubMed
    24. Hoffman DA, Debattista C, Valuck RJ, Iosifescu DV. Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review. Neuropsychiatr Dis Treat. 2012; 8:277-84.
      View in: PubMed
    25. Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA. Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study. J Allergy Clin Immunol. 2012 Aug; 130(2):368-75.
      View in: PubMed
    26. Slejko JF, Libby AM, Nair KV, Valuck RJ, Campbell JD. Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States. Res Social Adm Pharm. 2013 Jan-Feb; 9(1):108-13.
      View in: PubMed
    27. Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther. 2012 Jan; 34(1):113-23.
      View in: PubMed
    28. Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT. Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US. Drug Healthc Patient Saf. 2011; 3:47-52.
      View in: PubMed
    29. Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Saf. 2011 Jul 01; 34(7):533-44.
      View in: PubMed
    30. Sanglier T, Saragoussi D, Milea D, Auray JP, Valuck RJ, Tournier M. Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis. J Am Geriatr Soc. 2011 Jul; 59(7):1197-205.
      View in: PubMed
    31. Henderson KC, Hindman J, Johnson SC, Valuck RJ, Kiser JJ. Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV. AIDS Patient Care STDS. 2011 Apr; 25(4):221-8.
      View in: PubMed
    32. Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):66-75.
      View in: PubMed
    33. Reiter PD, Huff AD, Knupp KG, Valuck RJ. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol. 2010 Aug; 43(2):117-21.
      View in: PubMed
    34. Libby AM, Pace W, Bryan C, Anderson HO, Ellis SL, Allen RR, Brandt E, Huebschmann AG, West D, Valuck RJ. Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes. Med Care. 2010 Jun; 48(6 Suppl):S39-44.
      View in: PubMed
    35. Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW. Metabolic screening in children receiving antipsychotic drug treatment. Arch Pediatr Adolesc Med. 2010 Apr; 164(4):344-51.
      View in: PubMed
    36. Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010 Jan; 67(1):17-24.
      View in: PubMed
    37. Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry. 2009 Aug; 70(8):1069-77.
      View in: PubMed
    38. Pace WD, Cifuentes M, Valuck RJ, Staton EW, Brandt EC, West DR. An electronic practice-based network for observational comparative effectiveness research. Ann Intern Med. 2009 Sep 01; 151(5):338-40.
      View in: PubMed
    39. Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry. 2009 Jun; 66(6):633-9.
      View in: PubMed
    40. Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure. Clin Ther. 2009 Mar; 31(3):632-43.
      View in: PubMed
    41. Williams-Skipp C, Raman T, Valuck RJ, Watkins H, Palmer BE, Scheinman RI. Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. Arthritis Rheum. 2009 Feb; 60(2):408-18.
      View in: PubMed
    42. Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry. 2008 Feb; 69(2):316-22.
      View in: PubMed
    43. Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008 Jan; 165(1):42-50.
      View in: PubMed
    44. Valuck RJ, Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Curr Med Res Opin. 2007 Oct; 23(10):2567-76.
      View in: PubMed
    45. Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007 Aug; 164(8):1198-205.
      View in: PubMed
    46. Baldessarini RJ, Tondo L, Strombom IM, Dominguez S, Fawcett J, Licinio J, Oquendo MA, Tollefson GD, Valuck RJ, Tohen M. Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry. 2007 Jul-Aug; 15(4):133-45.
      View in: PubMed
    47. Reiter PD, Valuck RJ, Taylor RS. Evaluation of off-label recombinant activated factor VII for multiple indications in children. Clin Appl Thromb Hemost. 2007 Jul; 13(3):233-40.
      View in: PubMed
    48. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007 Jun; 164(6):884-91.
      View in: PubMed
    49. Glassman PA, Belperio P, Lanto A, Simon B, Valuck R, Sayers J, Lee M. The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc. 2007 Jul-Aug; 14(4):424-31.
      View in: PubMed
    50. McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol. 2007 Aug; 60(8):812-8.
      View in: PubMed
    51. McClure DL, Valuck RJ, Glanz M, Hokanson JE. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiol Drug Saf. 2007 Feb; 16(2):132-43.
      View in: PubMed
    52. Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther. 2007 Jan; 29(1):183-95.
      View in: PubMed
    53. Reiter PD, Novak K, Valuck RJ, Rosenberg AA, Fish D. Effect of a closed drug-delivery system on the incidence of nosocomial and catheter-related bloodstream infections in infants. Epidemiol Infect. 2006 Apr; 134(2):285-91.
      View in: PubMed
    54. Reiter PD, Rosenberg AA, Valuck R, Novak K. Effect of short-term erythropoietin therapy in anemic premature infants. J Perinatol. 2005 Feb; 25(2):125-9.
      View in: PubMed
    55. Valuck R. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s). Am J Manag Care. 2004 Apr; 10(4):285; author reply 286.
      View in: PubMed
    56. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004 Apr; 57(4):422-8.
      View in: PubMed
    57. Ganther-Urmie JM, Nair KV, Valuck R, McCollum M, Lewis SJ, Turpin RS. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans. Am J Manag Care. 2004 Mar; 10(3):201-8.
      View in: PubMed
    58. Sullivan PW, Valuck R, Saseen J, MacFall HM. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs. 2004; 18(13):911-32.
      View in: PubMed
    59. Nair KV, Valuck RJ. Consumer responses to a pharmacy benefit report card. J Health Care Finance. 2004; 31(1):55-72.
      View in: PubMed
    60. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs. 2004; 18(15):1119-32.
      View in: PubMed
    61. Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clin Ther. 2003 Nov; 25(11):2936-57.
      View in: PubMed
    62. Reiter PD, Sims C, Harmes L, Paisley J, Rosenberg AA, Valuck RJ. Calfactant sterility in multiple doses from single-use vials. Ann Pharmacother. 2003 Sep; 37(9):1219-23.
      View in: PubMed
    63. Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. J Manag Care Pharm. 2003 Mar-Apr; 9(2):123-33.
      View in: PubMed
    64. Nair KV, Ganther JM, Valuck RJ, McCollum MM, Lewis SJ. Impact of multi-tiered pharmacy benefits on attitudes of plan members with chronic disease states. J Manag Care Pharm. 2002 Nov-Dec; 8(6):477-91.
      View in: PubMed
    65. Roose SP, Katz IR, Pollock BG, Valuck RJ. Contemporary issues in the diagnosis and treatment of late-life depression. J Am Med Dir Assoc. 2002 Jul-Aug; 3(4 Suppl):H26-9.
      View in: PubMed
    66. Ruscin JM, Page RL, Valuck RJ. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother. 2002 May; 36(5):812-6.
      View in: PubMed
    67. Vander Zanden JA, Valuck RJ, Bunch CL, Perlman JI, Anderson C, Wortman GI. Systemic adverse effects of ophthalmic beta-blockers. Ann Pharmacother. 2001 Dec; 35(12):1633-7.
      View in: PubMed
    68. Valuck RJ, Perlman JI, Anderson C, Wortman GI. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers. Pharmacoepidemiol Drug Saf. 2001 Oct-Nov; 10(6):511-6.
      View in: PubMed
    69. Sherman DS, Clarke SH, Lefkowitz JB, Valuck RJ, Lindenfeld J, Stringer KA. An institution-specific heparin titration nomogram: development, validation, and assessment of compliance. Pharmacotherapy. 2001 Oct; 21(10):1167-74.
      View in: PubMed
    70. Carter BL, Malone DC, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Dombrowski R, Geraets DR, Amato M. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 2001 Jul 15; 58(14):1330-7.
      View in: PubMed
    71. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Okano GJ, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Geraets DR, Amato MG. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care. 2001 Feb; 39(2):113-22.
      View in: PubMed
    72. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, Barnette DJ, Sintek CD, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Dombrowski R, Geraets DR, Amato M. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 Dec; 20(12):1508-16.
      View in: PubMed
    73. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Okano GJ, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Geraets DR, Amato MG. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 Oct; 20(10):1149-58.
      View in: PubMed
    74. Reiter PD, Rosenberg AA, Valuck RJ. Factors associated with successful epoetin alfa therapy in premature infants. Ann Pharmacother. 2000 Apr; 34(4):433-9.
      View in: PubMed
    75. Billups SJ, Okano G, Malone D, Carter BL, Valuck R, Barnette DJ, Sintek CD. Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers. Am J Health Syst Pharm. 2000 Jan 01; 57(1):29-39.
      View in: PubMed
    76. Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators. J Clin Epidemiol. 1999 Jun; 52(6):551-7.
      View in: PubMed
    77. Carter BL, Malone DC, Valuck RJ, Barnette DJ, Sintek CD, Billups SJ. The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Am J Health Syst Pharm. 1998 Jan 01; 55(1):62-7.
      View in: PubMed
    78. Lambert BL, Salmon JW, Stubbings J, Gilomen-Study G, Valuck RJ, Kezlarian K. Factors associated with antibiotic prescribing in a managed care setting: an exploratory investigation. Soc Sci Med. 1997 Dec; 45(12):1767-79.
      View in: PubMed
    79. Moore LL, Valuck R, McDougall C, Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception. 1995 Oct; 52(4):215-9.
      View in: PubMed
    80. Valuck RJ, Poirier S, Mrtek RG. Patent medicine muckraking: influences on American pharmacy, social reform, and foreign authors. Pharm Hist. 1992; 34(4):183-92.
      View in: PubMed
    Valuck's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
    Physical Neighbors
    _

    Copyright © 2012 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.5.1)